Business Advisory services                  Life Sciences Consulting                  Product Development                  ANDAs                  FTFs                  505 b 2 a                  Late Stage Assets                  Phase-II Trials                  Marketing Authorizationís                  Dossiers                  Site Transfers                  Scale ups                   Tail End Brands                  Technologies and Know-how                  Project Management                   Business Excellence & Six Sigma
A US-based biotechnology company planned to significantly increase clinical trial work with an expanding Indian organization. The existing infrastructure was deemed incapable of delivering the projected number of clinical sites and subjects and to maintain high quality standards.The organization also desired higher site and country productivity in Asia & Europe.
The Garphi team completed a detailed diagnostic investigation, including interviews with all affiliates to define issues and identify options, analyzed the data and proposed a new organization& some practical recommendations. The program was approved and successfully implemented.